|

VenObi+Ven or VenObi+VenZan Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Gruppo Italiano Malattie EMatologiche dell'Adulto1

Indications

  • High Risk CLL1
  • Chronic Lymphocytic Leukemia1
  • Cancer1

Other1 trial

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.